Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-08
2011-03-08
Goddard, Laura B (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07902165
ABSTRACT:
The present invention relates to novel uses of AIM3 acting as a tumor suppressor, and more particularly to methods for using an AIM3 protein or a nucleic acid encoding the protein to activate ATM or ATR and to treat ATM- or ATR-mediated diseases. The AIM3 protein according to the present invention interacts directly with ATM/ATR so as to activate ATM/ATR and proteins regulated by ATM/ATR. Also, the AIM3 protein upregulates tumor suppressor gene p53 and its target genes so as to not only inhibit the proliferation of cells but also to induce apoptosis.
REFERENCES:
patent: WO 99/46292 (1999-09-01), None
Zips et al. (2005, In Vivo, 19:1-7).
Rolland (Advanced Drug Delivery Reviews, 2005, 57:669-673).
McNeish et al (Gene Therapy, 2004, 11:497-503).
McCormick (Nature Reviews, 2001, 1:130-141).
Park et al (Cell, 2005, 120:209-221).
Rho et al., “Genetic dissection of protein-protein interactions in mult-tRNA synthetase complex,”Proc. Natl. Acad. Sci., 1999, vol. 96, pp. 4488-4493, National Academy of Sciences, Washington, D.C.
Ko et al., “Novel regulatory interactions and activities of mammalian tRNA synthetases,”Proteomics, 2002, vol. 2, pp. 1304-1310, Wiley-VCH Verlag GmbH & Co., Germany.
Quevillon et al., “The p18 component of the multisynthetase complex shares a protein motif with the β and γ subunits of eukaryotic elongation fact 1,”FEBS Letters, 1996, vol. 395, pp. 63-67, Elsevier Science BV, Amsterdam, Holland.
Mao et al., “Identification of genes expressed in human CD34+ hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning,”Proc. Natl. Acad. Sci., 1998, vol. 95, pp. 8175-8180, National Academy of Sciences, Washington, D.C.
Buchanan & Ingersoll & Rooney PC
Goddard Laura B
Seoul National University Industry Foundation
LandOfFree
Use of AIM3 acting as a tumor suppressor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of AIM3 acting as a tumor suppressor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of AIM3 acting as a tumor suppressor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2764312